Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry

American Journal of Hematology

Volumn 84, Issue 10, 2009, Pages 636-640

  Melillo, Lorella ^a   Tieghi, A ^m   Candoni, A ⁿ   Radaelli, F ^o   Ciancia, R ^e   Specchia, G ^f   Martino, B ^g   Scalzulli, P R ^a   Latagliata, R ^h   Palmieri, F ⁱ   Usala, E ^j   Valente, D ^a   Cascavilla, N ^a   Cedrone, M ^k   Comitini, G ^l   Martinelli, V ^e   Cascavilla, Nicola ^a   Gugliotta, L ^a,m   Valvano, M R ^a   Fanin, R ⁿ   Iurlo, A ^o   Zanella, A ^o   Rotoli, B ^e   Carluccio, P ^f   Liso, V ^f   Nobile, F ^g   Santoro, C ^h   Mazzucconi, M G ^h   Cantore, N ⁱ   Angelucci, E ^j   Annino, L ^k   Cacciola, E ^p   Cacciola, R ^p   Giustolisi, R ^p   Fanci, R ^q   Bosi, A ^q   Frungillo, N ^r   Corradini, P ^r   Patriarca, A ^s   Dragani, A ^s   De Muro, M ^t   Avvisati, G ^t   more..

^a Hematology Unit   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g Hematology Unit   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ Hematology Unit   (Italy)

^j Hematology Unit   (Italy)

^k Hematology   (Italy)

^l Obstetrics Unit   (Italy)

^m Hematology Unit   (Italy)

ⁿ Department of Experimental Clinical Medicine   (Italy)

^o Fondazione Ca Granda IRCCS Policlinico   (Italy)

^p UNIVERSITY OF CATANIA   (Italy)

^q UNIVERSITY OF FLORENCE   (Italy)

^r NATIONAL CANCER INSTITUTE   (Italy)

^s Hematology   (Italy)

^t UNIVERSITY CAMPUS BIO MEDICO   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; BIRTH RATE; CONTROL GROUP; DEEP VEIN THROMBOSIS; FEMALE; FETUS WASTAGE; GENE MUTATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; ITALY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; POPULATION; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; STILLBIRTH; THROMBOCYTHEMIA; THROMBOCYTOPENIA; WILD TYPE;

ADOLESCENT; ADULT; ASPIRIN; FEMALE; HUMANS; INTERFERON TYPE I, RECOMBINANT; ITALY; JANUS KINASE 2; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PARITY; PLATELET COUNT; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; REGISTRIES; RETROSPECTIVE STUDIES; THROMBOCYTHEMIA, ESSENTIAL; YOUNG ADULT;

EID: 70349499203     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21504     Document Type: Article

References (27)

1. Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasm: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008;22:2118-2119.
2. Gugliotta L, Marchioli R, Fiacchini M, et al. Epidemiological, diagnostic, therapeutic and prognostic aspects of essential thrombocythemia in a retrospective study of GIMMC in two thousand patients. Blood 1997;90:348a.
3. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283-291.
4. Barbui T, Barosi G, Grossi A, et al. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematolgy and the Italian Group for Bone Marrow Transplantation. Haematologica 2004;89:215-232.
5. Harrison C. Pregnancy and its management in the Philadelphia negative myeloproliferative diseases. Br J Haematol 2005;129:293-306. (Pubitemid 40646888)
6. Passamonti F, Randi ML, Rumi E, et al. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (V617F) mutation. Blood 2007;110:485-489.
7. Griesshammer M, Struve S. Barbui T. Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy. Blood Rev 2008;22:235-245.
8. Gangat N, Wolanskyj AP, Schwager S, Tefferi A. Predictors of pregnancy outcome in essential thrombocythemia: A single institution study of 63 pregnancies. Eur J Haematol 2009;82:350-353.
9. Wright CA, Tefferi A. A single institutional experience with 43 pregnancies in essential thrombocythemia. Eur J Haematol 2001;66:152-159. (Pubitemid 32324581)
10. Vantroyen B, Vanstraelen D. Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. Acta Haematol 2002;107:158-169.
11. Gunter HH, Scharf A, Hillemans P, et al. Pregnancies without prenatal care which women are potentially affected, what are inherent fetal risks? Z Geburtshilfe Neonatol 2007;211:27-32.
12. Falconer J, Pineo G, Blahey W, et al. Essential thrombocythemia associated with recurrent abortions and fetal growth retardation. Am J Hematol 1987;25:345-347. (Pubitemid 17103189)
13. Bates SM, Ginsberg JS. Thrombosis in pregnancy. Curr Opin Hematol 1997;4:335-343.
14. Cheung B, Radia D, Pantedelis P, et al. The presence of the JAK2 V617F mutation is associated with higher hemoglobin and increased risk of thrombosis in essential Thrombocythemia. Br J Haematol 2005;132:244-250. (Pubitemid 43381559)
15. Ziakas PD. Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: Measuring the uncertain. Haematologica 2008;93:1412-1414.
16. Niittyvuopio R, Juvonen E, Kaaja R, et al. Pregnancy in essential thrombocythemia: Experience with 40 pregnancies. Eur J Haematol 2004;73:431-436. (Pubitemid 39564367)
17. Pons JC, Lebon P, Frydman R, Delfraissy JF. Pharmacokinetics of interferon-alpha in pregnant women and fetoplacental passage. Fetal Diagn Ther 1995;10:7-10.
18. Kumar AR, Hale TW, Mock RE. Transfer of interferon alfa into human breast milk. J Hum Lact 2000;16:226-228.
19. Martinelli P, Martinelli V, Agangi A, et al. Interferon alfa treatment for pregnant women affected by essential thrombocythemia: Case reports and a review. Am J Obstet Gynecol 2004;191:2016-2020. (Pubitemid 39601507)
20. Iwashita T, Fujitani M, Yamamoto Y, et al. Interferon-alfa treatment of essential thrombocythemia during pregnancy. Intern Med 2006;45:1161-1164. (Pubitemid 44773968)
21. Demmers KJ, Derecka K, Flint A. Trophoblast interferon and pregnancy. Reproduction 2001;121:41-49.
22. Kiladjan JJ, Casadevall N, Vainchenker W, Fenaux P. The first international meeting on V617F JAK2 mutation and its relevance in Philadelphia-negative myeloproliferative disorders. Pathol Biol 2007;55:85-87. (Pubitemid 46412670)
23. Elliott MA, Tefferi A. Thrombocythemia and pregnancy. Best Pract Res Clin Haematol 2003;16:227-242.
24. Doubek M, Brychtova Y, Doubek R, et al. Anagrelide therapy in pregnancy: Report of a case of essential thrombocythemia. Ann Hematol 2004;83:726-727. (Pubitemid 39440219)
25. Murphy S, Illand H, Rosenthal D, Laslzo J. Experience of the polycythemia Vera study Group with essential thrombocythemia: A final report on diagnostic criteria, survival and leukemic transition by treatment. Semin Hematol 1997;34:29-39. (Pubitemid 27063140)
26. Imbert M, Pierre R, Thiele J, et al. Essential thrombocythemia. In: Jaffe ES, Harris NL, Stein H, et al., editors. WHO Classification of Tumors. Tumors of Hematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. pp 39-41.
27. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;365:1054-1061. (Pubitemid 40386783)